{"id":37098,"date":"2018-01-16T09:00:00","date_gmt":"2018-01-16T07:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/?post_type=press_release&#038;p=37098"},"modified":"2023-09-07T14:54:59","modified_gmt":"2023-09-07T12:54:59","slug":"ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/","title":{"rendered":"Ipsen annonce 13 posters et 1 pr\u00e9sentation orale lors du Symposium sur les Cancers Gastro-intestinaux de l\u2019ASCO\u00a0"},"content":{"rendered":"<p><b>Ipsen va co-organiser une r\u00e9union pour la communaut\u00e9 financi\u00e8re pour discuter des donn\u00e9es pr\u00e9sent\u00e9es \u00e0 l\u2019ASCO-GI 2018<\/b><\/p>\n<p><b>Paris (France),<\/b> <b>le 15 janvier 2018 \u2013 <\/b>Ipsen (Euronext : IPN ; ADR : IPSEY) a annonc\u00e9 aujourd\u2019hui que l\u2019irinot\u00e9can liposomal pour injection (Onivyde\u00ae), le cabozantinib (Cabometyx\u00ae), le lanr\u00e9otide (Somatuline\u00ae Autogel\u00ae \/ Depot\u00ae), et le t\u00e9lotristat \u00e9thyl (Xermelo\u00ae) feront l\u2019objet de 11 posters, auxquels s\u2019ajouteront 2 posters traitant des patients atteints de tumeurs neuroendocrines, lors du Symposium 2018 sur les Cancers Gastro-intestinaux (ASCO-GI) de l\u2019<em>American Society of Clinical Oncology<\/em>, qui se tiendra du 18 au 20 janvier 2018 \u00e0 San Francisco (CA, Etats-Unis). <b>Le cabozantinib (Cabometyx<\/b><b>\u00ae<\/b><b>) fera \u00e9galement l\u2019objet d\u2019une pr\u00e9sentation orale :<\/b><\/p>\n<p><b>Pr\u00e9sentation orale B<\/b> \u2013 Cancers du pancr\u00c9as, de l\u2019intestin gr\u00cale et des voies h\u00c9patobiliaires<u> Vendredi 19 janvier : 14h15 \u2013 15h45 (Pacific Time)<\/u><\/p>\n<ul>\n<li style=\"margin-bottom:3px\">Abstract 207 :<\/li>\n<\/ul>\n<p>Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: results from the randomized phase 3 CELESTIAL trial.<br \/>\nAuteur principal : Ghassan Abou-Alfa, MD<br \/>\n<em>\u00ab Avec 13 posters portant sur des r\u00e9sultats cliniques dans le cancer du pancr\u00e9as, le carcinome h\u00e9pato-cellulaire avanc\u00e9, les tumeurs neuroendocrines et le syndrome carcino\u00efde, Ipsen conna\u00eetra une forte pr\u00e9sence en oncologie lors de l\u2019ASCO-GI 2018. Avec notre partenaire Exelixis, nous attendons avec impatience que les r\u00e9sultats de CELESTIAL, l\u2019\u00e9tude pivotale de phase 3 \u00e9valuant le cabozantinib chez les patients atteints d\u2019un carcinome h\u00e9patocellulaire avanc\u00e9 pr\u00e9c\u00e9demment trait\u00e9, soient partag\u00e9s pour la premi\u00e8re fois avec la communaut\u00e9 m\u00e9dicale, le 19 janvier \u00bb, <\/em><b>a d\u00e9clar\u00e9 Alexandre Lebeaut, MD, Vice-Pr\u00e9sident ex\u00e9cutif, R&amp;D et Chief Scientific Officer d\u2019Ipsen.<\/b><\/p>\n<p><b><u>Le nal-IRI \/ irinot\u00e9can liposomal pour injection (Onivyde<\/u><\/b><b><u>\u00ae<\/u><\/b><b><u>) fera l\u2019objet de 7 abstracts\/posters lors de 2 sessions de pr\u00e9sentations de posters :<\/u><\/b><br \/>\n<b>Pr\u00e9sentation de poster Session B <\/b><b>\u2013<\/b><b> Cancers du pancr\u00c9as, de l\u2019intestin gr\u00cale et des voies h\u00c9patobiliaires<\/b><br \/>\n<u>Pr\u00e9sentation de poster, le vendredi 19 janvier : 11h30 \u2013 13h et 17h30 \u2013 18h30 (Pacific Time)<\/u><\/p>\n<ul>\n<li style=\"margin-bottom:3px\">TABLEAU F20 \u2013 (Abstract 335)<br \/>\nDeposition characteristics and resulting DNA damage patterns of liposomal irinotecan (nal-IRI) in pancreatic cancer xenografts.<br \/>\nAuteur principal : Shannon Leonard<\/li>\n<\/ul>\n<ul>\n<li style=\"margin-bottom:3px\">TABLEAU H16 \u2013 (Abstract 379)<br \/>\nSubgroup analysis by baseline pain intensity (BPI) and analgesic use (BAU) in NAPOLI-1: A phase III study of liposomal irinotecan (nal IRI)\u00b15-fluorouracil\/ leucovorin (5-FU\/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy.<br \/>\nAuteur principal : Teresa Macarulla, MD, PhD<\/li>\n<\/ul>\n<ul>\n<li style=\"margin-bottom:3px\">TABLEAU J2 \u2013 (Abstract 388)<br \/>\nDose modifications of liposomal irinotecan (nal-IRI) + 5-fluorouracil\/leucovorin (5-FU\/LV) in NAPOLI-1: Impact on efficacy.<br \/>\nAuteur principal : Andrea Wang-Gillam, MD, PhD<\/li>\n<\/ul>\n<ul>\n<li style=\"margin-bottom:3px\">TABLEAU K3 \u2013 (Abstract 410)<br \/>\nSubgroup analysis by baseline (BL) weight-associated parameters: A phase III study of liposomal irinotecan (nal IRI)\u00b15 fluorouracil\/leucovorin (5 FU\/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based (gem) therapy.<br \/>\nAuteur principal : Teresa Macarulla, MD, PhD<\/li>\n<\/ul>\n<ul>\n<li style=\"margin-bottom:3px\">TABLEAU M6 \u2013 (Abstract 459)<br \/>\nNomogram for predicting overall survival (OS) in patients (pts) treated with liposomal irinotecan (nal-IRI) \u00b1 5-fluorouracil\/leucovorin (5-FU\/LV) in metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy in NAPOLI-1.<br \/>\nAuteur principal : Andrea Wang-Gillam, MD, PhD<\/li>\n<\/ul>\n<ul>\n<li style=\"margin-bottom:3px\">TABLEAU M7 \u2013 (Abstract 460)<br \/>\nSubgroup analysis by measurable metastatic lesion (ML) number and selected lesion locations (LL) at baseline (BL) in NAPOLI 1: A phase III study of liposomal irinotecan (nal IRI)\u00b15 fluorouracil\/leucovorin (5 FU\/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy.<br \/>\nAuteur principal : Jens Siveke, Prof. Dr. med.<\/li>\n<\/ul>\n<p><b>Pr\u00e9sentation de poster Session C <\/b><b>\u2013 <\/b><b>Cancers du c\u00f4lon, du rectum et de l\u2019anus<\/b><br \/>\n<u>Pr\u00e9sentation de poster, le samedi 20 janvier : 7h \u2013 7h55 et 11h30 \u2013 13h (Pacific Time)<\/u><\/p>\n<ul>\n<li style=\"margin-bottom:3px\">TABLEAU G24 \u2013 (Abstract 711)<\/li>\n<\/ul>\n<p>Influence of liposomal irinotecan (nal-IRI) and non-liposomal irinotecan, alone and in combination, on tumor growth and angiogenesis in colorectal cancer (CRC) models.<br \/>\nAuteur principal : Annette Larsen, DVM, PhD<\/p>\n<p><b><u>Le cabozantinib (Cabometyx\u00ae) fera l\u2019objet de 2 pr\u00e9sentations :<\/u><\/b><\/p>\n<p><b>Pr\u00e9sentation orale Session B<\/b> \u2013 Cancers du pancr\u00c9as, de l\u2019intestin gr\u00cale et des voies h\u00c9patobiliaires <u>Vendredi 19 janvier : 14h15 \u2013 15h45 (Pacific Time)<\/u><\/p>\n<ul>\n<li style=\"margin-bottom:3px\">Abstract 207 :<\/li>\n<\/ul>\n<p>Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: results from the randomized phase 3 CELESTIAL trial.<br \/>\nAuteur principal : Ghassan Abou-Alfa, MD<\/p>\n<p><b>Pr\u00e9sentation de poster Session B \u2013 <\/b>Cancers du pancr\u00c9as, de l\u2019intestin gr\u00cale et des voies h\u00c9patobiliaires <u>V<\/u><u>endredi 19 janvier : 11h30 \u2013 13h et 17h30 \u2013 18h30 (Pacific Time)<\/u><\/p>\n<ul>\n<li style=\"margin-bottom:3px\">TABLEAU A4 \u2013 (Abstract 207)<br \/>\nCabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: results from the randomized phase 3 CELESTIAL trial.<br \/>\nAuteur principal : Ghassan Abou-Alfa, MD<\/li>\n<\/ul>\n<p><b><u>Le lanr\u00e9otide (Somatuline\u00ae Autogel\u00ae \/ Depot\u00ae) fera l\u2019objet d\u2019une pr\u00e9sentation de poster :<\/u><\/b><br \/>\n<b>Pr\u00e9sentation de poster Session B \u2013 <\/b><b>Cancers du pancr\u00c9as, de l\u2019intestin gr\u00cale et des voies h\u00c9patobiliaires<\/b><br \/>\n<u>Pr\u00e9sentation de poster, le vendredi 19 janvier : 11h30 \u2013 13h et 17h30 \u2013 18h30 (Pacific Time)<\/u><\/p>\n<ul>\n<li style=\"margin-bottom:3px\">TABLEAU G8 \u2013 (Abstract 347)<br \/>\nLanreotide for the prolonged control of carcinoid syndrome (CS) in somatostatin analog (SSA)-na\u00efve or experienced patients.<br \/>\nAuteur principal : Edward Wolin, MD<\/li>\n<\/ul>\n<p><b><u>La recherche clinique sur les tumeurs neuroendocrines fera l\u2019objet de pr\u00e9sentations lors d\u2019une session de pr\u00e9sentations de poster :<\/u><\/b><br \/>\n<b>Pr\u00e9sentation de poster Session B \u2013 <\/b><b>Cancers du pancr\u00c9as, de l\u2019intestin gr\u00cale et des voies h\u00c9patobiliaires <\/b><u>Vendredi 19 janvier : 11h30 \u2013 13h et 17h30 \u2013 18h30<\/u><u> (Pacific Time)<\/u><\/p>\n<ul>\n<li style=\"margin-bottom:3px\">TABLEAU G20 \u2013 (Abstract 359)<br \/>\nLiving with neuroendocrine tumors: Assessing quality of life (QoL) through a mobile application.<br \/>\nAuteur principal : Jared Adams, MD, PhD<\/li>\n<li style=\"margin-bottom:3px\">TABLEAU E8 \u2013 (Abstract 299)<br \/>\nPhysical, emotional, and informational challenges of patients living with neuroendocrine tumors in the United States: Understanding their unmet needs.<br \/>\nAuteur principal : Grace Goldstein<\/li>\n<\/ul>\n<p><b><u>Le t\u00e9lotristat \u00e9thyl (Xermelo<\/u><\/b><b><u>\u00ae<\/u><\/b><b><u>) fera l\u2019objet d\u2019une pr\u00e9sentation de poster<\/u><\/b><br \/>\n<b>Pr\u00e9sentation de poster Session B \u2013 <\/b><b>Cancers du pancr\u00c9as, de l\u2019intestin gr\u00cale et des voies h\u00c9patobiliaires <\/b><u>V<\/u><u>endredi 19 janvier : 11h30 \u2013 13h et 17h30 \u2013 18h30 (Pacific Time)<\/u><\/p>\n<ul>\n<li style=\"margin-bottom:3px\">TABLEAU J9 \u2013 (Abstract 395)<br \/>\nTime to sustained improvement in bowel movement frequency with telotristat ethyl: Analysis of the phase III TELECAST study.<br \/>\nAuteur principal : Joseph Dillon<\/li>\n<\/ul>\n<p>Nota bene : Les indications autoris\u00e9es pour les produits peuvent varier d\u2019un pays \u00e0 l\u2019autre et toutes les indications ne sont pas disponibles dans tous les pays. Les profils de tol\u00e9rance et d\u2019efficacit\u00e9 des produits ne peuvent pas encore \u00eatre \u00e9tablis hors des indications autoris\u00e9es.<\/p>\n<p><img src='https:\/\/ml-eu.globenewswire.com\/media\/Nzg4MmYyYjktMDMxMS00NjY4LWFmNDktMGZiOWNmOWQ0ZjJiLTEwMTA5NDM=\/tiny\/Ipsen-SA.png' \/><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[149,1763],"tags":[],"class_list":["post-37098","press_release","type-press_release","status-publish","hentry","category-pressrelease","category-corporate-pressrelease","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ipsen annonce 13 posters et 1 pr\u00e9sentation orale lors du Symposium sur les Cancers Gastro-intestinaux de l\u2019ASCO\u00a0<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen annonce 13 posters et 1 pr\u00e9sentation orale lors du Symposium sur les Cancers Gastro-intestinaux de l\u2019ASCO\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-07T12:54:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/media\/Nzg4MmYyYjktMDMxMS00NjY4LWFmNDktMGZiOWNmOWQ0ZjJiLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/\"},\"author\":{\"name\":\"IPSEN\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/05e5e9dcc9e44c61de10732d1d0a1352\"},\"headline\":\"Ipsen annonce 13 posters et 1 pr\u00e9sentation orale lors du Symposium sur les Cancers Gastro-intestinaux de l\u2019ASCO\u00a0\",\"datePublished\":\"2018-01-16T07:00:00+00:00\",\"dateModified\":\"2023-09-07T12:54:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/\"},\"wordCount\":1063,\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/Nzg4MmYyYjktMDMxMS00NjY4LWFmNDktMGZiOWNmOWQ0ZjJiLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"articleSection\":[\"Press Releases\",\"Corporate\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/\",\"url\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/\",\"name\":\"Ipsen annonce 13 posters et 1 pr\u00e9sentation orale lors du Symposium sur les Cancers Gastro-intestinaux de l\u2019ASCO\u00a0\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/Nzg4MmYyYjktMDMxMS00NjY4LWFmNDktMGZiOWNmOWQ0ZjJiLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"datePublished\":\"2018-01-16T07:00:00+00:00\",\"dateModified\":\"2023-09-07T12:54:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/#primaryimage\",\"url\":\"https:\/\/ml-eu.globenewswire.com\/media\/Nzg4MmYyYjktMDMxMS00NjY4LWFmNDktMGZiOWNmOWQ0ZjJiLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"contentUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/Nzg4MmYyYjktMDMxMS00NjY4LWFmNDktMGZiOWNmOWQ0ZjJiLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ipsen annonce 13 posters et 1 pr\u00e9sentation orale lors du Symposium sur les Cancers Gastro-intestinaux de l\u2019ASCO\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/05e5e9dcc9e44c61de10732d1d0a1352\",\"name\":\"IPSEN\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b569564123e1c5c4bb45b008fc273d5bfdd6464d8a8497307ebbe91af50ed000?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b569564123e1c5c4bb45b008fc273d5bfdd6464d8a8497307ebbe91af50ed000?s=96&d=mm&r=g\",\"caption\":\"IPSEN\"},\"sameAs\":[\"https:\/\/www.ipsen.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen annonce 13 posters et 1 pr\u00e9sentation orale lors du Symposium sur les Cancers Gastro-intestinaux de l\u2019ASCO\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/","og_locale":"fr_FR","og_type":"article","og_title":"Ipsen annonce 13 posters et 1 pr\u00e9sentation orale lors du Symposium sur les Cancers Gastro-intestinaux de l\u2019ASCO\u00a0","og_url":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/","og_site_name":"Global","article_modified_time":"2023-09-07T12:54:59+00:00","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/media\/Nzg4MmYyYjktMDMxMS00NjY4LWFmNDktMGZiOWNmOWQ0ZjJiLTEwMTA5NDM=\/tiny\/Ipsen-SA.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@ipsengroup","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/#article","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/"},"author":{"name":"IPSEN","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/05e5e9dcc9e44c61de10732d1d0a1352"},"headline":"Ipsen annonce 13 posters et 1 pr\u00e9sentation orale lors du Symposium sur les Cancers Gastro-intestinaux de l\u2019ASCO\u00a0","datePublished":"2018-01-16T07:00:00+00:00","dateModified":"2023-09-07T12:54:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/"},"wordCount":1063,"publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/Nzg4MmYyYjktMDMxMS00NjY4LWFmNDktMGZiOWNmOWQ0ZjJiLTEwMTA5NDM=\/tiny\/Ipsen-SA.png","articleSection":["Press Releases","Corporate"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/","url":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/","name":"Ipsen annonce 13 posters et 1 pr\u00e9sentation orale lors du Symposium sur les Cancers Gastro-intestinaux de l\u2019ASCO\u00a0","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/Nzg4MmYyYjktMDMxMS00NjY4LWFmNDktMGZiOWNmOWQ0ZjJiLTEwMTA5NDM=\/tiny\/Ipsen-SA.png","datePublished":"2018-01-16T07:00:00+00:00","dateModified":"2023-09-07T12:54:59+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/#primaryimage","url":"https:\/\/ml-eu.globenewswire.com\/media\/Nzg4MmYyYjktMDMxMS00NjY4LWFmNDktMGZiOWNmOWQ0ZjJiLTEwMTA5NDM=\/tiny\/Ipsen-SA.png","contentUrl":"https:\/\/ml-eu.globenewswire.com\/media\/Nzg4MmYyYjktMDMxMS00NjY4LWFmNDktMGZiOWNmOWQ0ZjJiLTEwMTA5NDM=\/tiny\/Ipsen-SA.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/ipsen-annonce-13-posters-et-1-presentation-orale-lors-du-symposium-sur-les-cancers-gastro-intestinaux-de-lasco\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Ipsen annonce 13 posters et 1 pr\u00e9sentation orale lors du Symposium sur les Cancers Gastro-intestinaux de l\u2019ASCO\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/fr\/#website","url":"https:\/\/www.ipsen.com\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/fr\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]},{"@type":"Person","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/05e5e9dcc9e44c61de10732d1d0a1352","name":"IPSEN","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b569564123e1c5c4bb45b008fc273d5bfdd6464d8a8497307ebbe91af50ed000?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b569564123e1c5c4bb45b008fc273d5bfdd6464d8a8497307ebbe91af50ed000?s=96&d=mm&r=g","caption":"IPSEN"},"sameAs":["https:\/\/www.ipsen.com"]}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/37098","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":2,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/37098\/revisions"}],"predecessor-version":[{"id":37100,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/37098\/revisions\/37100"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media?parent=37098"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/categories?post=37098"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/tags?post=37098"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}